Pearce IP BioBlast™: w/e 15 January 2021

by | Jan 19, 2021

07 Jan 21 | ADQ announced it will acquire Pharmax Pharmaceuticals, as well as investing in a minority stake in Biocon Biologics.

13 Jan 21 | Kamada
announced it has entered into agreements with two undisclosed international pharmaceutical companies to commercialise three biosimilar product candidates in Israel.

15 Jan 21 | Celltrion
announced it has submitted an investigational new drug application for Ph III trials of CT-P41 (proposed denosumab biosimilar).
Print Page Mail Article

Get our Pearce IP Blogs & BioBlast® sent directly to your inbox

Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.

Our Latest News